scispace - formally typeset
J

Jo Vandesompele

Researcher at Ghent University

Publications -  406
Citations -  67052

Jo Vandesompele is an academic researcher from Ghent University. The author has contributed to research in topics: Neuroblastoma & microRNA. The author has an hindex of 88, co-authored 383 publications receiving 59368 citations. Previous affiliations of Jo Vandesompele include Washington University in St. Louis & Ghent University Hospital.

Papers
More filters
Journal ArticleDOI

Quality control of digital PCR assays and platforms.

TL;DR: It is found that a robust weighted least-squares approach is highly advisable, yet may also suffer from an inflated false-positive rate and the proposed assessments are also applicable to other analyses, such as the comparison of results obtained from qPCR and dPCR.
Journal ArticleDOI

A unified censored normal regression model for qPCR differential gene expression analysis

TL;DR: This work proposes a novel method that unites preprocessing and differential expression analysis in a single statistical model that provides a rigorous way for handling undetermined Cq values and shows that this method outperforms traditional RT-qPCR differential expressionAnalysis pipelines in the presence of undetermined values, both in terms of accuracy and precision.
Journal ArticleDOI

In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors.

TL;DR: A novel ESC m(i)RNA signature stratifies neuroblastomas with poor prognosis, enabling the identification of therapy-resistant tumors and warrants for drug design targeted at FOXM1 or key components controlling this pathway.
Journal ArticleDOI

Localization and Expression of Nuclear Factor of Activated T-Cells 5 in Myoblasts Exposed to Pro-inflammatory Cytokines or Hyperosmolar Stress and in Biopsies from Myositis Patients.

TL;DR: In muscle biopsies from dermatomyositis and polymyositis patients, NFAT5 colocalized with HDAC6, while in IBM, this was often absent, and disturbed myogenicNFAT5 physiology could possibly explain deleterious effects on muscle regeneration in myositis.